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This study investigates how long-term (40 mg/kg b.wt) consumption of aspartame can
alter the antioxidant status, stress pathway genes, and apoptotic changes in the liver of
Wistar albino rats. Numerous controversial reports are available on the use of aspartame
as it releases methanol as one of its metabolites during metabolism. To mimic the
human methanol metabolism the methotrexate treated rats were included to study the
aspartame effects. The aspartame treated methotrexate (MTX animals showed a marked
significant increase in the superoxide dismutase (SOD), catalase (CAT), lipid peroxidation
(LPO), and Glutathione peroxidase (GPx) activity in the liver from control and MTX control
animals, and showed a significant decrease in reduced glutathione (GSH) and protein
thiol in aspartame treated animals. The aspartame treated MTX animals showed a
marked significant decrease in the body weight, brain, and liver weight. The aspartame
treated MTX animals showed a marked increase in the inducible nitric oxide (iNOS),
neuronal nitric oxide (nNOS), c-fos, Heat shock protein (Hsp) 70 Tumour necrosis Factor
(TNF)a, caspase 8, c-jun N terminal kinases (JNK) 3 and Nuclear factor kappa B (NFkB)
gene expression in the liver from control and MTX control animals. The aspartame
treated MTX animals showed a marked increase in the c-fos, Hsp 70, iNOS Caspase 8, and
JNK 3 protein expression in the liver from control and MTX control animals indicating the
enhancement of stress and apoptosis. The aspartame treated MTX animals showed a
streak of marked DNA fragmentation in the liver. On immunohistochemical analysis
aspartame treated animals showed brown colored positive hepatocytes indicating the
stress specific and apoptotic protein expression. Since aspartame consumption is on the
rise among people, it is essential to create awareness regarding the usage of this artificial
sweetener.
Copyright © 2015, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC.
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In this modern world people are used to having carbonated
beverages along with food intake which contains the artificial
sweetener aspartame (N-alpha-aspartyl-L-phenylalanine),
and it is known that prolonged aspartame consumption leads
to risk due to the formation of metabolites, especially meth-
anol (10%), aspartic acid (40%), and phenylalanine (50%), [1,2].
There are not many studies describing the misuse and intake
of aspartame on health, that exceeds the recommended
maximum daily intake of aspartame 40 mg/kg bodyweight in
Europe and 50 mg/kg bodyweight in the United States [3]. But
children and adults consume aspartame unintentionally to a
larger amount in excess than the Food and Drugs Adminis-
tration (FDA) approval [4] which leads to serious health com-
plications because of its metabolites. Aspartame is also
present in puddings, fillings, and chewing gum [5]. Approxi-
mately 375 million people consume 2000 tons of aspartame
per year in Europe. Upon consumption of aspartame, its me-
tabolites increase in the blood [6] and are mainly metabolized
by the liver, since the liver is the chief organ in the breakdown,
where xenobiotics of drugs and chemicals metabolism takes
place to a large extent. Astonishingly, sometimes the de-
rivatives of those breakdown substances are more toxic than
the original substance itself [7]. Methanol is being docu-
mented as a substance that harms the liver cells when it gets
oxidized to formaldehyde and formate [8]. Oxidation of
methanol causes development of peroxides which leads to
denaturation, fragmentation of proteins, and alteration of
enzymatic properties [9], even organisms evolve in such away
with effective antioxidant defense mechanism [10]. One of
these is Hsp70, which protect cells against a variety of stresses
[11] that induces the production of ROS that act in response
over the cellular molecules such as lipids, proteins, and DNA.
Nitric oxide (NO), is a molecule, naturally synthesized in all
cells, since it has a short half-life and is very difficult to
measure but it has been found that it can be measured by
Nitric oxide synthase (NOS) activity [12]. It facilitates many of
the physiological functions [13] and protects the body from
superoxide radicals, also involved in the regulation of
apoptosis [14], it has three isoforms, namely neuronal NOS
(nNOS), inducible NOS (iNOS), and endothelial NOS (eNOS). Of
these nNOS and eNOS are structural enzymes, which are
found in many cells. Nitric oxide production is mediated by
the stimulation of nitric oxide synthases, its production is
either toxic or protective and it depends on the expression, in
the liver which has both cytoprotective and cytotoxic effects
[13]. The prolonged consumption of aspartame resulted in
increasedmethanol and itsmetabolites which are responsible
for the generation of oxidative stress [15]. Body cells guard
themselves against Reactive oxygen species (ROS) damage
through antioxidants under regular conditions, but in excess
it deranges our antioxidant system from balance and in-
creases production of NO resulting in damage, because NO
reacts in a diffusion controlled process to produce peroxyni-
trite. Also, it stimulates one of the main inflammatory
markers NF-kB [16] and results in inflammation. Soffritti et al,
[17] reported that aspartame consumption leads to a carci-
nogenic effect on the system which has a deleterious effectcausing the whole body damage, including mainly liver
damage. There is a scarcity of studies on the evidence of stress
specific genes and extrinsic apoptotic effect of aspartame in
the liver and the effect may be due to the generation of per-
oxynitrile free radicals that produce chromatin DNA clumping
and apoptosis. Aspartame has a negative effect on the liver
indirectly, mainly because of its metabolites. In this study we
have added a folate deficient group to specifically find the
methanol and formaldehyde effects which are metabolites of
aspartame, the rodents do not develop metabolic acidosis
during methanol poisoning, owing to their high liver folate
content and in order to create similar results in humans only
folate deficient rodents are required to accumulate formate in
order to develop acidosis [18,19]. Hence, in this study, in order
to mimic the human situation, a folate deficiency status is
induced by administering methotrexate. Beyond the aspar-
tame toxicity studies in the enzymatic level, its effect on the
molecular stress and apoptotic pathways are scarce. In this
present investigation, an attempt has been made to study
whether the long term consumption of aspartame can alter
the antioxidant status and stress pathway genes iNOS, nNOS,
c-fos, and Hsp 70 followed by apoptotic changes in TNFa,
caspase 8, JNK 3, and NFkB in the liver of Wistar albino rats.2. Materials and methods
2.1. Animals
Wistar strain male albino rats (200e220 g) were maintained
under standard laboratory conditionswithwater and food. For
the folate-deficient group, a folate-deficient diet was provided
for 45 days prior to the experiment and methotrexate (MTX)
was administered for 1 week prior to the experiment. The
animals were handled according to the principles of labora-
tory care framed by the Committee for the Purpose of Control
and Supervision of Experiments on Animals (CPCSEA), Gov-
ernment of India. Prior to the experimentation, proper
approval was obtained from the Institutional Animal Ethical
Committee (No: 01/032/2010/Aug-11), Dr. ALM Post Graduate
Institute of Basic Medical Sciences, University of Madras,
Taramani, Chennai-113, TN, India.
2.2. Chemicals
Aspartame and methotrexate were purchased from Sigma
chemical company, St. Louis, MO, USA. Nitric oxide assay kit
was purchased from Biovision Inc, Milpitas, CA, USA. Taq-
Polymerase, DNTPs from (Genet Bio Inc, Yuseong-gu Dae-
jeon, Korea) China, reverse transcription (RT) enzyme kit from
(Thermo Fisher Scientific Inc, MA, USA), and other molecular
grade chemicals from Merck Bangalore, India. All other
chemicals were of analar grade obtained from Sisco research
Laboratory, Bombay, India.
2.3. Experimental design
The European Food Safety Authority recently confirmed an
acceptable daily intake (ADI) for aspartame of 40 mg/kg b.wt./
d. In order to confine within the human permitted exposure
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line was administered orally (40 mg/kg body weight) and this
dosage was based on the FDA approved ADI limit.
The rats were divided into three groups, namely, saline
control, MTX-treated control, and MTX-treated aspartame
administered groups. Each group consisted of six animals.
MTX in sterile saline was administered (0.2 mg/kg/d) subcu-
taneously for 7 days to folate-deficient control as well as to
folate-deficient aspartame treated groups [20]. One week after
treatment with MTX, folate deficiency was confirmed by
estimating the urinary excretion of formiminoglutamic acid
(FIGLU) [21]. From the 8th day, only the MTX-treated aspar-
tame group received the aspartame, whereas the other two
groups received equivalent volumes of saline as an oral dose
and all animals were handled similarly. The chronic dose of
aspartame was given for 90 days and all the animals were fed
a folate-deficient diet except the control animals for 90 days.
2.4. Sample collections
The animals were sacrificed using a higher dose of long acting
pentothal sodium (100 mg/kg.b.wt). The blood samples and
isolation of liver was performed between 8 AM and 10 AM to
avoid circadian rhythm induced changes. The liver was
immediately removed and washed with ice-cold phosphate
buffered saline (PBS). Further dissection wasmade on ice-cold
glass plates. The homogenate (10% w/v) of the individual re-
gions were prepared in a Teflon-glass tissue homogenizer,
using ice-cold PBS (100 mm, pH 7.4) buffer and centrifuged
separately in a refrigerated centrifuge at 10,000 g for 15 mi-
nutes. The supernatant was used for analyzing the parame-
ters in this study.
2.5. Body weight and organ weight ratio
Body weight was checked between the groups and the organ
weight of the liver and brain were studied.
2.6. Free radical scavenging enzymes
Interference of free radicals in auto-oxidation of pyrogallol is
used as a convenient assay for superoxide dismutase (SOD;
EC.1.15.1.1) and expressed as units/min/mg protein [22]. For
catalase (EC.1.11.1.6) assay, standard hydrogen peroxide
(0.2M) was used as a substrate and the catalase activity was
terminated at intervals of 0-, 15-, 30-, and 60-seconds by
addition of potassium dichromateeacetic acid reagent and is
expressed as units/min/mg protein [23].
2.7. Nonenzymatic antioxidant estimations
The level of lipid peroxidation (LPO) was expressed as nano-
moles of malondialdehyde (an intermediary product of lipid
peroxidation, using thiobarbituric acid)/mg protein [24].
Reduced glutathione (GSH) was measured by its reaction with
5,50-dithiobis-(2-nitrobenzoic acid (DTNB), to form a com-
pound that absorbs at 412 nm [25]. The level of GSH is
expressed as mg of GSH/mg of protein. Protein bound (i.e., in
the membrane plus the soluble fraction) sulfhydryl concen-
tration was determined by the method of Sedlak and Lindsay[26] by subtracting the nonprotein sulfhydryl content from the
total sulfhydryl content. Tissues were homogenized in 0.02M
EDTA solution and analyzed for protein and sulfhydryl
concentration.
2.8. Isolation of total RNA and reverse transcription-
polymerized chain reaction (RT-PCR)
Total RNA was isolated from cells using Trizol reagent
following the method of Chomczynski and Sacchi [27]. The
total RNA obtained was free from protein and DNA contami-
nation. The reverse transcription stepwas performed by using
the RT enzyme kit. Each 20 mL reactionmixture contained 5 mL
OligodT (10mM), 1 mL dNTP(10mM), 4 mL First Strand buffer (5),
1 ml DTT (0.1 M), 0.2 mL super script III reverse transcriptase
(200U/mL) varied quantity of RNA template (dependent on RNA
concentration), and RNase free water to make up the volume.
Thermal cycling conditions for the first strand reaction con-
sisted of 25C for 5 minutes, 50C for 45 minutes, 70C for 15
minutes, and finally maintained at 4C for 5 minutes. PCR
amplificationwas performedusing TaqDNAPolymerase. Each
20 mL of sample contained 10 mLMastermix (2mM), 1 mL forward
primer, and 1 mL reverse primer for both genes of interest and
internal control consecutively, 2 mL RT sample, and 4 mL sterile
water. The mixture was kept at thermocycler and amplified
for 35 cycles. Each thermocycling consisted of 94C for 30
seconds, varied annealing temperature for each gene of in-
terest for 30 seconds, and 72C for 30 seconds. b-Actin gene
was coamplified with the gene of interest using the same
procedures. The sense and antisense primer for the study is
tabulated in Table 1. Ten microliters of each PCR product was
analyzed by gel electrophoresis on 2% agarose gel.
Agarose gel electrophoresis is an effective method for the
identification of purified DNA molecules [28]. Amplified
product was analyzed by agarose gel electrophoresis with
ethidium bromide staining. Then the gel containing cDNAwas
visualized with the help of fluorescent imager (Bio-Rad Labo-
ratories, Hercules, CA). The band intensity was quantified by
Quantity One Software. The band intensification for each
enzyme mRNA was normalized with that of the internal
control b-actin using Quantity One Software.
2.9. Immunoblotting
Tissue lysate was prepared with radio immuno assay buffer
(RIPA; Sigma aldrich, St louis, USA) and protease inhibitor.
Equal amounts of protein (60 mg) were electrophoresed on 10%
SDSePAGE. Following electrophoresis, separated proteins on
SDSePAGE gels were transferred on to a Polyvinylidene
difluoride (PVDF) membrane (Millipore, USA). To block the
nonspecific binding, the membranes were incubated in a
blocking buffer with 5% skimmed milk for 2 hours. Mem-
branes were probed with primary antibodies (Biovision). Blots
were incubated with horse radish peroxidase-conjugated
secondary antibodies (1:10,000; Merck). The bands were
developed using ECL kit (Millipore) in Chemi Doc image
scanner from Bio-Rad. The band intensity was quantified by
Quantity One software (Bio-Rad). The membranes were
stripped and reprobed for b-actin (Sigma; 1:5000) as an inter-
nal control.
Table 2 e Effect of aspartame (40 mg/kg b.wt.) on body
weight and organ weight (g).a
Parameter Control MTX control Asp þ MTX
treated*
Body weight (g) 303.83 ± 27.06 295.16 ± 13.10 270.5 ± 10.13b,c
Liver weight (g) 3.66 ± 0.24 3.45 ± 0.10 3.08 ± 0.07b,c
Brain weight (g) 2.05 ± 0.06 1.85 ± 0.10 1.50 ± 0.06b,c
The data from various groups for the individual parameters are
presented as a bar diagram with mean ± SD.
* Significance fixed at p < 0.05.
a Comparison and analysis were done by the one-way analysis of
variance (ANOVA), (n ¼ 6) control group was compared with the
MTX group and aspartame MTX group, the MTX group was
compared with the aspartame MTX group. Control, MTX control-
methotrexate treated group, Asp þ MTX-
aspartame þ methotrexate treated group.
b Aspartame treated group when compared to control significance.
c MTX treated group significance when compared to control
significance.
Table 1 e The sense and antisense primer sequences of the gene of interest for PCR amplification.
Gene Sequence Amplified product (bp) Annealing temp/cycles
TNF-a Sense: CTCCCAGAAAAGCAAGCAAC
Antisense: CGAGCAGGAATGAGAAGAGG
210 55C/35
NFkB Sense: CATCTTCAACATGGCAGACGACGA
Antisense: TGGGCCATCTGTTGACAGTGGTAT
130 55C/35
JNK3 Sense: AACAATCGCTACACCTCCAAAGAC
Antisense: GGCAATAGATGACACATCCACG
330 56C/35
Casp8 Sense: GCGACAGGTTACAGCTCTCC
Antisense: GCAGCCTCTGAAATAGCACC
180 55C/35
b-actin Sense: TCATGCCATCCTGCGTCTGGACCT
Antisense: CGGACTCATCGTACTCCTGCTTG
598 55C/35
Hsp70 Sense: GAGTCCTACGCCTTCAATATGAAG
Antisense: CATCAAGAGTCTGTCTCTAGCCAA
347 55C/35
iNOS Sense: TCTGTGCCTTTGCTCATGAC
Antisense: CATGGTGAACACGTTCTTGG
305 55C/35
nNOS Sense: CCTTCCGAAGCTTCTGGCAACAGC
Antisense: TGGACTCAGATCTAAGGCGGTTGG
474 66C/35
c-fos Sense: AGTGGTGAAGACCATGTCAGG
Antisense: CATTGGGGATCTTGCAGG
296 55C/35
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The isolation of DNA from animal tissue was done according
to themethod of Iwasa et al [29] with somemodifications. The
tissue was homogenized in TE buffer and the suspension was
treated with the lysis buffer and kept in a water bath for 12
hours at 37C. DNAwas extracted twice with equal volumes of
a phenol, chloroform, and isoamylalcohol. To the aqueous
phase 1/10 volume of 3M sodium acetate was added and DNA
was extracted with 0.7 volume of chilled isopropanol.
Following an addition of 70% ethanol the precipitated DNA
was resuspended in 50ml of Tris EDTA buffer. DNA samples
were electrophoresed in 0.8% agarose gel containing ethidium
bromide and the gel was examined under UV light. A 1 kb
ladder and 100 bp ladder was used as the molecular weight
marker.
2.11. Histopathology
Animals were deeply anesthetized with ketamine hydro-
chloride. Rats were then perfused transcardially with
phosphate-buffered saline, followed by buffered 10%
formalin. The kidney was removed, and preserved in formalin
until processed for histology. Then running water was used to
remove formalin pigments and dehydrated with ascending
grades of alcohol. After impregnation with paraffin wax, the
paraffin blocks were made. They were processed and sections
were cut into 6 mm thickness using “Spencer Lens”, rotatory
microtome (Spencers Laboratory, No. 820, NewYork, NY, USA)
and then stained with haematoxylin and eosin stain as fol-
lowed for the kidney.
2.12. Immunohistochemical analysis
Immunohistochemical analysis was carried out using the 3,3'-
diaminobenzidine tetrahydrochloride (DAB) universal stain-
ing kit (Merck Genie, Bengaluru, India). The sections were
deparaffinized in xylene and dehydrated in ethanol. After
washing with PBS, slides were incubated with 3% H2O2 atroom temperature for 15 minutes to quench endogenous
peroxidase activity. After antigen retrieval (15 minutes of
autoclaving in 10mM citrate buffer, pH 6.0), the slides were
incubated with blocking solution (10% normal goat serum) for
5 minutes at room temperature. Then, the sections were
incubated overnight with a primary antibody. Subsequently,
the sections were incubated with Horse radish peroxidase
(HRP) secondary link antibody for 30 minutes at room tem-
perature, and washed with PBS. Then, the sections were
treated with DAB chromogen for 15 minutes. Finally, the
sections were washed with deionized water, counter stained
with haematoxylin, and mounted. Photographs were taken
using a Nikon microscope (Nikon Japan DS-Fi1).
2.13. Statistical analysis
Statistical analysis was carried out using the SPSS version 17.0
(SPSS Inc., Chicago, IL, USA). The results are expressed as
mean ± SD and the data were analyzed by the one-way
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Fig. 1 e (A) Effect of aspartame (40 mg/kg b.w) on
superoxide dismutase (SOD) activity (units/mg of tissue
protein) in rat liver. (B) Effect of aspartame (40 mg/kg b.w)
on catalase (CAT) activity (H2O2 utilized/min/mg protein) in
rat liver. (C) Effect of aspartame (40 mg/kg b.w) on reduced
glutathione (GSH) concentration (mg of GSH/mg of protein)
in rat liver. (D) Effect of aspartame (40 mg/kg b.w) on lipid
peroxidation (LPO) (Moles of MDA/mg tissue) in rat liver. (E)
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comparison tests when there is a significant “F” test ratio. The
level of significance was fixed at p  0.05.3. Results
The data from various groups for the individual parameters
are presented as a bar diagram and a table with mean ± SD.
3.1. Body and organ weight
The results are given in Table 2.The body weight, brain, and
liver weight in the MTX treated animals did not significantly
differ from the controls. However, the aspartame treated MTX
animals showed a marked significant decrease in the body
weight, brain, and liver weight from the control as well as
from the MTX treated control animals.
3.2. Free radical scavenging enzymes
The data from various groups are presented as a bar diagram
with mean ± SD (Fig. 1A). Activity of superoxide dismutase
(SOD) was increased significantly in aspartame treated MTX
animals respectively in the liverwhen compared to the control
and MTX treated control. However, the control did not signif-
icantly deviate from the MTX treated control animals. The
activity of catalase (CAT; Fig. 1B) was increased markedly in
the liver of aspartame treatedMTX animalswith respect to the
control and MTX treated control. However, the control did not
significantly deviate from the MTX treated control animals.
3.3. Nonenzymatic antioxidants
The results are given in Fig. 1C. The level of reduced gluta-
thione (GSH) was decreased in the liver of aspartame treated
MTX animals when compared to the control and MTX treated
control. The control and the MTX treated controls did not
significantly differ from each other. The level of lipid peroxi-
dation (LPO; Fig. 1D) was increased markedly in the liver of
aspartame treated MTX animals when compared to the con-
trol and MTX treated control. The control as well as MTX
treated controls showed similar lipid per oxidation levels. The
sulfhydryl (thiol; Fig. 1E) content of membrane proteins was
decreased markedly in the aspartame treated MTX animals
when compared to the control and MTX treated control. The
control as well as MTX treated animals show similar results.Effect of aspartame (40 mg/kg b.w) on protein thiol (mg/mg
protein) in rat liver. Comparison and analysis were done by
the one-way analysis of variance, (n¼ 6) control group was
compared with the MTX control group and aspartame MTX
group. Significance fixed at p < 0.05. The data from various
groups for the individual parameters are presented as bar
diagram with mean ± SD. aAspartame treated group when
compared to control significance. bMTX treated groups
when compared to control significance. Control ¼ MTX
controlemethotrexate treated group; MTX þ Asp ¼
methotrexate þ aspartame treated group.
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Fig. 2 e Effect of long term aspartame on iNOS, nNOS, Hsp 70, and C-fos mRNA expression in liver of Wistar albino rats.
aAspartame treated group when compared to the control significance. bMTX treated groups significance. Lane 1 ¼ control;
Lane 2 ¼ MTX control; Lane 3 ¼ Aspartame þ MTX treated; Lane M ¼ 100 bp marker.
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Fig. 3 e Effect of long term aspartame on TNFa, NF-kB, Caspase 8 and JNK3 mRNA expression in liver of Wistar albino rats.
aAspartame treated group when compared to the control significance. bMTX treated groups significance. Lane 1 ¼ control;
Lane 2 ¼ MTX control; Lane 3 ¼ aspartame þ MTX treated; Lane M ¼ 100 bp marker.
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The results are given in Fig. 2. Using b-Actin as an internal
control the stress specific genes, such as iNOS, nNOS, c-fos,
and Hsp 70, gene expression was studied. The iNOS, nNOS, c-
fos, and Hsp 70 gene expression in the MTX control animals
did not significantly (p < 0.05) differ from the controls. How-
ever, the aspartame treated MTX animals showed a marked
increase in the iNOS, nNOS, c-fos, and Hsp 70 gene expressionβ-actin
(42 kDa)
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Fig. 4 e Effect of long term aspartame on Caspase-8, JNK3, c-Fo
albino rats. Comparison and analysis were done by the one-wa
with the MTX control group and aspartame MTX group; the MT
group. aAspartame treated group when compared to the contro
1 ¼ control; Lane 2 ¼ MTX control; Lane 3 ¼ aspartame þ MTXin the liver from the control and MTX control animals indi-
cating the enhancement of stress.
The results are given in Fig. 3. The TNFa, caspase 8, JNK 3,
and NF-кB gene expression was studied by using b-Actin as an
internal control. The TNFa, caspase 8, JNK 3, and NF-кB gene
expression in the MTX control animals did not differ from the
controls. However, the aspartame treated MTX animals
(p < 0.05) showed a marked increase in the TNFa, caspase 8,
JNK 3, and NF-кB gene expression in the liver from the controlJN
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s, Hsp 70, and iNOS protein expression in liver of Wistar
y analysis of variance, (n ¼ 6) control group was compared
X control group was compared with the aspartame MTX
l significance. bMTX treated groups significance. Lane
treated.
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apoptosis.
3.5. Protein expression by immunoblotting
The results are given in Fig. 4. Using b-Actin as an internal
control the c-fos, Hsp 70, iNOS Caspase 8, and JNK 3 protein
expression was studied. The c-fos, Hsp 70, iNOS Caspase 8,
and JNK 3 protein expression in the MTX control animals did
not significantly (p < 0.05) differ from the controls. However,
the aspartame treated MTX animals showed a marked in-
crease in the c-fos, Hsp 70, iNOS, Caspase 8, and JNK 3 protein
expression in the liver from the control and MTX control an-
imals indicating the enhancement of stress and apoptosis.
3.6. DNA fragmentation by agarose gel electrophoresis
The results are given in Fig. 5. The effect of 90 days aspartame
(40 mg/kg b.wt.) administration to Wistar albino rats on DNA
fragmentation by agarose gel electrophoresis in the liver was
assessed. The DNA was found intact in the MTX treated ani-
mals and the controls. However, the aspartame treated MTX
animals showed a streak ofmarked DNA fragmentation in the
liver when compared to the control and MTX controls.
3.7. Histopathology
The results are given in Fig. 6. There was a significant change
in the kidney of aspartame treated MTX animals whenFig. 5 e DNA fragmentation assay by agarose gel
electrophoresis. Effect of 90 days aspartame (40 mg/
kg b.wt.) administration to Wistar albino rats on DNA
fragmentation by agarose gel electrophoresis in liver.
Lane 1 ¼ control; Lane 2 ¼ MTX control; Lane
3 ¼ MTX þ aspartame; M ¼ 100 bp marker; Ma ¼ 1 kb
marker.compared to the control and MTX control animals. In the
renal cortex, marked glomerular damages were noted
including the loss of normal architecture and reduction in
their normal sizes. The overall results indicate that
aspartame is effective in bringing about changes at cellular
levels.
3.8. Immunohistochemistry
The results are given in Figs. 7 and 8. There was a significant
change in the protein expression (immunohistochemistry) of
Hsp 70, c-fos, iNOS, nNOS, and JNK 3 protein in the liver of
aspartame treated MTX animals when compared to the con-
trol and MTX control animals. The photomicrograph shows a
significant amount of hepatocytes which underwent immuno
reactions and brown colored positive hepatocytes which
clearly indicates the apoptotic protein expression in the liver.
The liver of aspartame treated animals showed a marked
significant increase in the immune-reaction when compared
to the control and MTX control liver. The overall results
indicate that aspartame is effective in bringing about changes
at the cellular level.4. Discussion
Besides the confusion and studies about the deleterious ef-
fect of aspartame on health, its consumption is growing day
by day mainly because of beverages, since 70% of aspartame
exists in soft drinks. People with diabetes consume aspar-
tame as one of the sugar substitutes [30] because of its low
calorie sweetener property [31], an unplanned increase in
the intake of aspartame is above the norm. The present
hypothesis is to analyze the effect of long term consumption
of aspartame on stress and apoptotic pathways in the liver.
After the administration of aspartame in human partici-
pants, the blood methanol concentration exceeded 2 mg/dL
[32]. Even a minor quantity of aspartame significantly raises
the methanol level in the plasma [33]. The prolonged con-
sumption of aspartame results in increased methanol and
its metabolites which are responsible for the generation of
oxidative stress [15]. Methanol has its own effect on the liver
mainly [34], and this is reliable with our observation which
shows a decrease in the weight of the liver in aspartame
treated MTX animals compared to the control and MTX
treated animals. The photomicrograph of the liver in the
present study shows a significant quantity of hepatocytes
underwent immune reactions displaying brown colored
positive hepatocytes which clearly indicate the apoptotic
consequence on the liver. Only the liver of aspartame
treated animals showed a marked significant increase in the
brown colored positive hepatocytes when compared to the
control and MTX control. This histological change probably
indicates by altering the antioxidant status by the formation
of peroxides and free radicals, since aspartame induces
oxidative stress in the liver and kidney [35e37]. It has many
deranging functions in our body because of the formation of
peroxides and free radicals. Normally the system has its own
protection from free radicals by using its endogenous anti-
oxidants like superoxide dismutase (SOD), catalase (CAT),
Fig. 6 e Effect of long term aspartame consumption (40 mg / kg bwt) on kidney in Wistar albino rats, the histomicrograph of
kidney stained by hematoxylin and eosin. Arrows indicate marked glomerular damage and the loss of normal architecture.
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 3 ( 2 0 1 5 ) 6 7 9e6 9 1688and GSH. Increased oxidative stress is accompanied with the
increased level of superoxides and free radicals [38]. Deple-
tion of GSH increases cell susceptibility to oxidative stress
[4]. Here oxidative stress occurs as a result of aspartame
metabolites, these altered status of both enzymatic and
nonenzymatic antioxidants in the system that includes SOD
activity, CAT activity, and LPO (lipid peroxidation) increased
significantly and GSH (reduced glutathione) and sulfhydryl
(thiol) was markedly decreased in the aspartame treated
MTX animals when compared to the control and MTX
treated control in the liver. However, the control did not
significantly deviate from the MTX treated control animals.
The oxidative stress followed by prolonged intake of aspar-
tame has been well demonstrated in this study by Hsp 70,iNOS, and nNOS expressions in the liver. Hsp 70 (which
normally protect the cells against a variety of stresses) even
if the heat shock response is protective, most of this pro-
tective response is induced by deleterious stimuli and cau-
ses cellular injury followed by apoptosis with significant
alterations in metabolism [39], the aspartame induced
oxidative stress in turn stimulates nitric oxide and perox-
ynitrate production. In long term exposure of oxygen radi-
cals and nitrogen oxide derivatives DNA undergoes damage
[40], and the results obtained in this study too shows DNA
fragmentation in the liver which further supports the con-
sequences followed by the long term consumption of
aspartame, because nitric oxide is a highly reactive molecule
it interacts with iron and inhibits mitochondrial respiration,
Fig. 7 e Effect of long term aspartame on Hsp 70, c-fos, and JNK3 protein expression in liver of Wistar albino rats by
immunohistochemistry.
j o u r n a l o f f o o d and d ru g an a l y s i s 2 3 ( 2 0 1 5 ) 6 7 9e6 9 1 689DNA synthesis, and cytotoxicity [41]. Due to its short half-
life and unstable nature, iNOS and nNOS expression are
the forms of NOS studied in the liver [42] which shows
increased gene and protein expression in the aspartame
treated MTX animals when compared to the control and
MTX control animals clearly demonstrating the hepatocel-
lular stress response to oxidative stress. Conversely the
iNOS and nNOS gene expression in the MTX control animals
did not significantly (p < 0.05) differ from the controls.
Oxidative stress increased the generation of reactive oxygen
mediating apoptosis by activating the translocation of nu-
clear factor-kappa B (NF-кB). TNF which acts as the sensor of
oxidative stress [43] plays a vital role in liver homeostasis
either in cell survival or death [44] but its action on liver cells
mainly depends on the NF-kB and JNK signaling [16] which
mediates caspase dependent cell death. Once the signaling
gets activated by the oxidative stress it leads the TNF release
[45]. TNF binds to TNF receptor 1 which leads to the acti-
vation of cleaving procaspase 8 to caspase 8 which directly
triggers caspase 3 and initiates apoptosis [44], which is well
demonstrated in this study by the increased expression of
gene and protein expression of caspase 8 in aspartame
treated MTX animals when compared to the control andMTX control animals. Hence our overall findings of this
study is evidence that long term consumption of aspartame
induces apoptosis and damage to the hepatocytes by
oxidative stress via the JNK-NF signaling. Still aspartame
usage is unavoidable because of its involvement in our daily
food items in several forms, hence its consumption has to be
controlled and the FDA has to bring awareness and firm
rules against the chronic consumption and usage among
people.5. Conclusion
The observed results support the toxic nature of aspartame
when consumed repeatedly for a prolonged period. The pre-
sent study reveals that aspartame administration alters the
enzyme activity in the liver by probably elevating the free
radical levels. The observed changes may be due to the
methanol or aspartame metabolite for the generation of free
radicals in the liver. Moreover, the long term aspartame
administration distorted the stress markers and proteins
leading to hepatotoxicity. Since aspartame consumption is on
the rise among people, it is essential to create awareness
Fig. 8 e Effect of long term aspartame on nNOS and iNOS protein expression in the liver of Wistar albino rats by
immunohistochemistry.
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 3 ( 2 0 1 5 ) 6 7 9e6 9 1690regarding the usage of this artificial sweetener. Further studies
are required to evaluate the effect of aspartame in the future.Conflicts of interest
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